Maria Panagiotopoulou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Panagiotopoulou has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Christian Ohmann
European Clinical Research Infrastructures Network (ECRIN), Düsseldorf, Germany
6 shared publications - Petr Holub
BBMRI-ERIC, Neue Stiftingtalstraße 2/B/6, Graz, 8010, Austria
4 shared publications - Jonathan J. Ewbank
Aix Marseille Univ, CNRS, INSERM, CIML, Turing Centre for Living Systems, Marseille, France
3 shared publications - Katja Moilanen
Finnish Social Science Data Archive, Tampere, 33014, Finland
3 shared publications - Mari Kleemola
Finnish Social Science Data Archive, Tampere, 33014, Finland
3 shared publications - Romain David
EOSC Task Force on FAIR Metrics and Data Quality, EOSC, Brussels, Belgium
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by CERN in Open Research Europe
What does good governance of federated biomedical data reuse look like? A scoping review protocol.
Background Federated reuse of participant-level biomedical data enables public health institutions, healthcare providers, and researchers to analyse data without moving it from its source, providing access to a more diverse data ecosystem. Data governance determines whether this reuse is trustworthy, addressing the legal, ethical, and technical questions raised when decentralised analysis balances privacy with utility. Effective governance is central to protecting participant rights, ensuring benefit sharing, and supporting equity while enabling collaboration across data sources. This scoping review will identify and synthesise recommendations for data governance in the federated reuse of biomedical data, focusing on how approaches address participant rights, benefit-sharing, inclusivity, and legal and ethical compliance, and how they vary across reuse mechanisms. Methods We will apply the Arksey and O’Malley framework to map current recommendations and best practices and to identify gaps. A search strategy developed in line with the PRESS guidelines was piloted and tailored for Ovid (MEDLINE), EMBASE, and Web of Science, and covers the period from January 2000 to the search date, without language or geographic limits. Title and abstract screening will be conducted by one reviewer with ASReview as the second reviewer; full-text screening by two independent reviewers; and data extraction by one reviewer, verified by a second. Stakeholder consultation will refine the charting framework and the interpretation of findings. Results As part of the review protocol, this article reports no results. The completed review will map governance models, chart how each addresses participant rights and benefit-sharing, and compare approaches across data types, technical architectures, geographies, and legal contexts. Conclusions The review will provide the first structured synthesis of data governance for federated reuse of biomedical data, informing efforts to build transparent, equitable, and scalable frameworks. Ethical approval is not required; the protocol was registered with Open Research Europe before searching, and results will be published open access.
- 25 September 2026
- Published by CERN in Open Research Europe
Open AccessWhat does good governance of federated biomedical data reuse look like? A scoping review protocol.
Background Federated reuse of participant-level biomedical data enables public health institutions, healthcare providers, and researchers to analyse data without moving it from its source, providing access to a more diverse data ecosystem. Data governance determines whether this reuse is trustworthy, addressing the legal, ethical, and technical questions raised when decentralised analysis balances privacy with utility. Effective governance is central to protecting participant rights, ensuring benefit sharing, and supporting equity while enabling collaboration across data sources. This scoping review will identify and synthesise recommendations for data governance in the federated reuse of biomedical data, focusing on how approaches address participant rights, benefit-sharing, inclusivity, and legal and ethical compliance, and how they vary across reuse mechanisms. Methods We will apply the Arksey and O’Malley framework to map current recommendations and best practices and to identify gaps. A search strategy developed in line with the PRESS guidelines was piloted and tailored for Ovid (MEDLINE), EMBASE, and Web of Science, and covers the period from January 2000 to the search date, without language or geographic limits. Title and abstract screening will be conducted by one reviewer with ASReview as the second reviewer; full-text screening by two independent reviewers; and data extraction by one reviewer, verified by a second. Stakeholder consultation will refine the charting framework and the interpretation of findings. Results As part of the review protocol, this article reports no results. The completed review will map governance models, chart how each addresses participant rights and benefit-sharing, and compare approaches across data types, technical architectures, geographies, and legal contexts. Conclusions The review will provide the first structured synthesis of data governance for federated reuse of biomedical data, informing efforts to build transparent, equitable, and scalable frameworks. Ethical approval is not required; the protocol was registered with Open Research Europe before searching, and results will be published open access.
- Open Access
- 8 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Implementation of Individual Patient Data (IPD) Sharing Strategies in the VACCELERATE Project: A Case Study of COVID-19 Vaccine Trials (Preprint)
BACKGROUND Sharing Individual Patient Data (IPD) from clinical trials is increasingly promoted to improve transparency, reproducibility, and scientific value. However, implementation remains challenging due to ethical, regulatory, and operational constraints, particularly in multinational studies. OBJECTIVE This study evaluates the implementation of IPD sharing strategies within three multinational COVID-19 vaccine trials (EU-COVAT-1 AGED, EU-COVAT-2 BOOSTAVAC, and EU-COVPT-1 CoVacc) conducted under the VACCELERATE platform, focusing on protocol integration, informed consent, anonymisation, and repository-based data governance. METHODS Data sharing strategies were prospectively integrated into all trial protocols. A harmonized informed consent template was developed to secure broad participant consent. Data collection followed Clinical Data Acquisition Standards Harmonization (CDASH) guidelines. A structured, risk-based anonymization methodology was applied to the IPD of the AGED trial, involving data minimization and transformation of quasi-identifiers. The anonymized IPD dataset and relevant trial metadata were prepared for deposition in the ECRIN Clinical Research Data Sharing Repository (crDSR), hosted within a secure trusted research environment, in a GDPR-compliant process. RESULTS All three trials included IPD sharing provisions in their protocols. Full implementation was achieved only in the EU-COVAT-1 AGED trial, which obtained ethics approval for the harmonised consent template and completed anonymisation and repository submission. Operational constraints and national regulatory differences prevented full implementation in the other trials. The EU-COVAT-1 AGED dataset was successfully deposited in the repository, enabling secure long-term preservation and controlled secondary access. CONCLUSIONS The VACCELERATE experience demonstrates that responsible IPD sharing is feasible when integrated early into trial design and supported by harmonised consent, robust anonymisation, and secure repository infrastructure. Persistent regulatory heterogeneity and resource limitations remain key barriers. Early planning and institutional support are essential to making FAIR data sharing routine in multinational clinical research. CLINICALTRIAL EudraCT 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-004526-29/DE/; 2021-004889-35; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004889-35; and 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004526-29 INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1016/j.ijid.2024.107161
- 8 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImplementation of Individual Patient Data (IPD) Sharing Strategies in the VACCELERATE Project: A Case Study of COVID-19 Vaccine Trials (Preprint)
BACKGROUND Sharing Individual Patient Data (IPD) from clinical trials is increasingly promoted to improve transparency, reproducibility, and scientific value. However, implementation remains challenging due to ethical, regulatory, and operational constraints, particularly in multinational studies. OBJECTIVE This study evaluates the implementation of IPD sharing strategies within three multinational COVID-19 vaccine trials (EU-COVAT-1 AGED, EU-COVAT-2 BOOSTAVAC, and EU-COVPT-1 CoVacc) conducted under the VACCELERATE platform, focusing on protocol integration, informed consent, anonymisation, and repository-based data governance. METHODS Data sharing strategies were prospectively integrated into all trial protocols. A harmonized informed consent template was developed to secure broad participant consent. Data collection followed Clinical Data Acquisition Standards Harmonization (CDASH) guidelines. A structured, risk-based anonymization methodology was applied to the IPD of the AGED trial, involving data minimization and transformation of quasi-identifiers. The anonymized IPD dataset and relevant trial metadata were prepared for deposition in the ECRIN Clinical Research Data Sharing Repository (crDSR), hosted within a secure trusted research environment, in a GDPR-compliant process. RESULTS All three trials included IPD sharing provisions in their protocols. Full implementation was achieved only in the EU-COVAT-1 AGED trial, which obtained ethics approval for the harmonised consent template and completed anonymisation and repository submission. Operational constraints and national regulatory differences prevented full implementation in the other trials. The EU-COVAT-1 AGED dataset was successfully deposited in the repository, enabling secure long-term preservation and controlled secondary access. CONCLUSIONS The VACCELERATE experience demonstrates that responsible IPD sharing is feasible when integrated early into trial design and supported by harmonised consent, robust anonymisation, and secure repository infrastructure. Persistent regulatory heterogeneity and resource limitations remain key barriers. Early planning and institutional support are essential to making FAIR data sharing routine in multinational clinical research. CLINICALTRIAL EudraCT 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-004526-29/DE/; 2021-004889-35; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004889-35; and 2021-004526-29; https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004526-29 INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1016/j.ijid.2024.107161
- Open Access
- 23 May 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (4)
Sharing sensitive data in life sciences: an overview of centralized and federated approaches
Biomedical data are generated and collected from various sources, including medical imaging, laboratory tests and genome sequencing. Sharing these data for research can help address unmet health needs, contribute to scientific breakthroughs, accelerate the development of more effective treatments and inform public health policy. Due to the potential sensitivity of such data, however, privacy concerns have led to policies that restrict data sharing. In addition, sharing sensitive data requires a secure and robust infrastructure with appropriate storage solutions. Here, we examine and compare the centralized and federated data sharing models through the prism of five large-scale and real-world use cases of strategic significance within the European data sharing landscape: the French Health Data Hub, the BBMRI-ERIC Colorectal Cancer Cohort, the federated European Genome-phenome Archive, the Observational Medical Outcomes Partnership/OHDSI network and the EBRAINS Medical Informatics Platform. Our analysis indicates that centralized models facilitate data linkage, harmonization and interoperability, while federated models facilitate scaling up and legal compliance, as the data typically reside on the data generator’s premises, allowing for better control of how data are shared. This comparative study thus offers guidance on the selection of the most appropriate sharing strategy for sensitive datasets and provides key insights for informed decision-making in data sharing efforts.
- 23 May 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (4)
Open AccessSharing sensitive data in life sciences: an overview of centralized and federated approaches
Biomedical data are generated and collected from various sources, including medical imaging, laboratory tests and genome sequencing. Sharing these data for research can help address unmet health needs, contribute to scientific breakthroughs, accelerate the development of more effective treatments and inform public health policy. Due to the potential sensitivity of such data, however, privacy concerns have led to policies that restrict data sharing. In addition, sharing sensitive data requires a secure and robust infrastructure with appropriate storage solutions. Here, we examine and compare the centralized and federated data sharing models through the prism of five large-scale and real-world use cases of strategic significance within the European data sharing landscape: the French Health Data Hub, the BBMRI-ERIC Colorectal Cancer Cohort, the federated European Genome-phenome Archive, the Observational Medical Outcomes Partnership/OHDSI network and the EBRAINS Medical Informatics Platform. Our analysis indicates that centralized models facilitate data linkage, harmonization and interoperability, while federated models facilitate scaling up and legal compliance, as the data typically reside on the data generator’s premises, allowing for better control of how data are shared. This comparative study thus offers guidance on the selection of the most appropriate sharing strategy for sensitive datasets and provides key insights for informed decision-making in data sharing efforts.
- Open Access
- 11 December 2023
- Published by CERN in Open Research Europe
- Vol. 3, 180
ECRIN – CESSDA strategies for cross metadata mappings in selected areas between life sciences and social sciences and humanities
Background The recent COVID-19 (Corona Virus Disease 2019) pandemic dramatically underlined the multi-faceted nature of health research, requiring input from basic biological sciences, pharmaceutical technologies, clinical research), social sciences and public health and social engineering. Systems that could work across different disciplines would therefore seem to be a useful idea to explore. In this study we investigated whether metadata schemas and vocabularies used for discovering scientific studies and resources in the social sciences and in clinical research are similar enough to allow information from different source disciplines to be easily retrieved and presented together. Methods As a first step a literature search was performed, exemplarily identifying studies and resources, in which data from social sciences have been usefully employed or integrated with that from clinical research and clinical trials. In a second step a comparison of metadata schemas and related resource catalogues in ECRIN (European Clinical Research Infrastructure Network) and CESSDA (Consortium of European Social Science Data Archives) was performed. The focus was on discovery metadata, here defined as the metadata elements used to identify and locate scientific resources. Results A close view at the metadata schemas of CESSDA and ECRIN and the basic discovery metadata as well as a crosswalk between ECRIN and CESSDA metadata schemas have shown that there is considerable resemblance between them. Conclusions The resemblance could serve as a promising starting point to implement a common search mechanism for ECRIN and CESSDA metadata. In the paper four different options for how to proceed with implementation issues are presented.
- 11 December 2023
- Published by CERN in Open Research Europe
- Vol. 3, 180
Open AccessECRIN – CESSDA strategies for cross metadata mappings in selected areas between life sciences and social sciences and humanities
Background The recent COVID-19 (Corona Virus Disease 2019) pandemic dramatically underlined the multi-faceted nature of health research, requiring input from basic biological sciences, pharmaceutical technologies, clinical research), social sciences and public health and social engineering. Systems that could work across different disciplines would therefore seem to be a useful idea to explore. In this study we investigated whether metadata schemas and vocabularies used for discovering scientific studies and resources in the social sciences and in clinical research are similar enough to allow information from different source disciplines to be easily retrieved and presented together. Methods As a first step a literature search was performed, exemplarily identifying studies and resources, in which data from social sciences have been usefully employed or integrated with that from clinical research and clinical trials. In a second step a comparison of metadata schemas and related resource catalogues in ECRIN (European Clinical Research Infrastructure Network) and CESSDA (Consortium of European Social Science Data Archives) was performed. The focus was on discovery metadata, here defined as the metadata elements used to identify and locate scientific resources. Results A close view at the metadata schemas of CESSDA and ECRIN and the basic discovery metadata as well as a crosswalk between ECRIN and CESSDA metadata schemas have shown that there is considerable resemblance between them. Conclusions The resemblance could serve as a promising starting point to implement a common search mechanism for ECRIN and CESSDA metadata. In the paper four different options for how to proceed with implementation issues are presented.
- Open Access
- 15 November 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (23) , e115008
“Be sustainable”: EOSC‐Life recommendations for implementation of FAIR principles in life science data handling
The main goals and challenges for the life science communities in the Open Science framework are to increase reuse and sustainability of data resources, software tools, and workflows, especially in large‐scale data‐driven research and computational analyses. Here, we present key findings, procedures, effective measures and recommendations for generating and establishing sustainable life science resources based on the collaborative, cross‐disciplinary work done within the EOSC‐Life (European Open Science Cloud for Life Sciences) consortium. Bringing together 13 European life science research infrastructures, it has laid the foundation for an open, digital space to support biological and medical research. Using lessons learned from 27 selected projects, we describe the organisational, technical, financial and legal/ethical challenges that represent the main barriers to sustainability in the life sciences. We show how EOSC‐Life provides a model for sustainable data management according to FAIR (findability, accessibility, interoperability, and reusability) principles, including solutions for sensitive‐ and industry‐related resources, by means of cross‐disciplinary training and best practices sharing. Finally, we illustrate how data harmonisation and collaborative work facilitate interoperability of tools, data, solutions and lead to a better understanding of concepts, semantics and functionalities in the life sciences.
- 15 November 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (23) , e115008
Open Access“Be sustainable”: EOSC‐Life recommendations for implementation of FAIR principles in life science data handling
The main goals and challenges for the life science communities in the Open Science framework are to increase reuse and sustainability of data resources, software tools, and workflows, especially in large‐scale data‐driven research and computational analyses. Here, we present key findings, procedures, effective measures and recommendations for generating and establishing sustainable life science resources based on the collaborative, cross‐disciplinary work done within the EOSC‐Life (European Open Science Cloud for Life Sciences) consortium. Bringing together 13 European life science research infrastructures, it has laid the foundation for an open, digital space to support biological and medical research. Using lessons learned from 27 selected projects, we describe the organisational, technical, financial and legal/ethical challenges that represent the main barriers to sustainability in the life sciences. We show how EOSC‐Life provides a model for sustainable data management according to FAIR (findability, accessibility, interoperability, and reusability) principles, including solutions for sensitive‐ and industry‐related resources, by means of cross‐disciplinary training and best practices sharing. Finally, we illustrate how data harmonisation and collaborative work facilitate interoperability of tools, data, solutions and lead to a better understanding of concepts, semantics and functionalities in the life sciences.
- Open Access
- 20 October 2023
- Published by CERN in Open Research Europe
- Vol. 3, 180
ECRIN – CESSDA strategies for cross metadata mappings in selected areas between life sciences and social sciences and humanities
Background: The recent COVID-19 pandemic dramatically underlined the multi-faceted nature of health research, requiring input from basic biological sciences, pharmaceutical technologies, clinical research), social sciences and public health and social engineering. Systems that could work across different disciplines would therefore seem to be a useful idea to explore. In this study we investigated whether metadata schemas and vocabularies used for discovering scientific studies and resources in the social sciences and humanities and in clinical research are similar enough to allow information from different source disciplines to be easily retrieved and presented together. Methods: As a first step a literature search was performed, exemplarily identifying studies and resources, in which data from social sciences and the humanities have been usefully employed or integrated with that from clinical research and clinical trials. In a second step a comparison of metadata schemas and related resource catalogues in ECRIN (European Clinical Research Infrastructure Network) and CESSDA (Consortium of European Social Science Data Archives) was performed. The focus was on discovery metadata, here defined as the metadata elements used to identify and locate scientific resources. Results: A close view at the metadata schemas of CESSDA and ECRIN and the basic discovery metadata as well as a crosswalk between ECRIN and CESSDA metadata schemas have shown that there is considerable resemblance between them. Conclusions: The resemblance could serve as a promising starting point to implement a common search mechanism for ECRIN and CESSDA metadata. In the paper four different options for how to proceed with implementation issues are presented.
- 20 October 2023
- Published by CERN in Open Research Europe
- Vol. 3, 180
Open AccessECRIN – CESSDA strategies for cross metadata mappings in selected areas between life sciences and social sciences and humanities
Background: The recent COVID-19 pandemic dramatically underlined the multi-faceted nature of health research, requiring input from basic biological sciences, pharmaceutical technologies, clinical research), social sciences and public health and social engineering. Systems that could work across different disciplines would therefore seem to be a useful idea to explore. In this study we investigated whether metadata schemas and vocabularies used for discovering scientific studies and resources in the social sciences and humanities and in clinical research are similar enough to allow information from different source disciplines to be easily retrieved and presented together. Methods: As a first step a literature search was performed, exemplarily identifying studies and resources, in which data from social sciences and the humanities have been usefully employed or integrated with that from clinical research and clinical trials. In a second step a comparison of metadata schemas and related resource catalogues in ECRIN (European Clinical Research Infrastructure Network) and CESSDA (Consortium of European Social Science Data Archives) was performed. The focus was on discovery metadata, here defined as the metadata elements used to identify and locate scientific resources. Results: A close view at the metadata schemas of CESSDA and ECRIN and the basic discovery metadata as well as a crosswalk between ECRIN and CESSDA metadata schemas have shown that there is considerable resemblance between them. Conclusions: The resemblance could serve as a promising starting point to implement a common search mechanism for ECRIN and CESSDA metadata. In the paper four different options for how to proceed with implementation issues are presented.
- Open Access
- 18 September 2023
- Published by Ubiquity Press, Ltd. in Data Science Journal
- Vol. 22 (1)
Umbrella Data Management Plans to Integrate FAIR Data: Lessons From the ISIDORe and BY-COVID Consortia for Pandemic Preparedness
The Horizon Europe project ISIDORe is dedicated to pandemic preparedness and responsiveness research. It brings together 17 research infrastructures (RIs) and networks to provide a broad range of services to infectious disease researchers. An efficient and structured treatment of data is central to ISIDORe’s aim to furnish seamless access to its multidisciplinary catalogue of services, and to ensure that users’ results are treated FAIRly. ISIDORe therefore requires a data management plan (DMP) covering both access management and research outputs, applicable over a broad range of disciplines, and compatible with the constraints and existing practices of its diverse partners. Here, we describe how, to achieve that aim, we undertook an iterative, step-by-step, process to build a community-approved living document, identifying good practices and processes, on the basis of use cases, presented as proof of concepts. International fora such as the RDA and EOSC, and primarily the BY-COVID project, furnished registries, tools and online data platforms, as well as standards, and the support of data scientists. Together, these elements provide a path for building an umbrella, FAIR-compliant DMP, aligned as fully as possible with FAIR principles, which could also be applied as a framework for data management harmonisation in other large-scale, challenge-driven projects. Finally, we discuss how data management and reuse can be further improved through the use of knowledge models when writing DMPs and, how, in the future, an inter-RI network of data stewards could contribute to the establishment of a community of practice, to be integrated subsequently into planned trans-RI competence centres.
- 18 September 2023
- Published by Ubiquity Press, Ltd. in Data Science Journal
- Vol. 22 (1)
Open AccessUmbrella Data Management Plans to Integrate FAIR Data: Lessons From the ISIDORe and BY-COVID Consortia for Pandemic Preparedness
The Horizon Europe project ISIDORe is dedicated to pandemic preparedness and responsiveness research. It brings together 17 research infrastructures (RIs) and networks to provide a broad range of services to infectious disease researchers. An efficient and structured treatment of data is central to ISIDORe’s aim to furnish seamless access to its multidisciplinary catalogue of services, and to ensure that users’ results are treated FAIRly. ISIDORe therefore requires a data management plan (DMP) covering both access management and research outputs, applicable over a broad range of disciplines, and compatible with the constraints and existing practices of its diverse partners. Here, we describe how, to achieve that aim, we undertook an iterative, step-by-step, process to build a community-approved living document, identifying good practices and processes, on the basis of use cases, presented as proof of concepts. International fora such as the RDA and EOSC, and primarily the BY-COVID project, furnished registries, tools and online data platforms, as well as standards, and the support of data scientists. Together, these elements provide a path for building an umbrella, FAIR-compliant DMP, aligned as fully as possible with FAIR principles, which could also be applied as a framework for data management harmonisation in other large-scale, challenge-driven projects. Finally, we discuss how data management and reuse can be further improved through the use of knowledge models when writing DMPs and, how, in the future, an inter-RI network of data stewards could contribute to the establishment of a community of practice, to be integrated subsequently into planned trans-RI competence centres.
- Open Access
- 14 June 2023
- Published by Pensoft Publishers in ARPHA Preprints
- Vol. 4, e107873
Improving COVID-19 metadata findability and interoperability in the European Open Science Cloud
This publication details the workplan of the Science Project (SP) “COVID-19 metadata findability and interoperability in EOSC” (short: META-COVID) that is part of the Horizon Europe funded project EOSC Future. The COVID-19 pandemic has generated a huge variety of research activities, studies, and policies across both the life sciences (LS) and the social sciences and humanities (SSH). Useful insights from combining the data and conclusions from these different forms of research are, however, hampered by the lack of a common metadata framework with which to describe them. This is because different scientific disciplines have different ways of organising research activities. For example, the type of the research (e.g., hypothesis testing versus hypothesis generating) and the methodology chosen (e.g., experimental, survey, cohort, case study) are key elements in understanding the data generated and in supporting its secondary use. Another issue to be tackled is the integration of various sources of metadata related to parliamentary and social media metadata. In META-COVID, scientists from the LS and SSH domains gathered to discuss ways in which metadata could go beyond the description of the data itself to include the basic elements of the research process (“contextual metadata”) within the frame of the European Open Science Cloud (EOSC). The main outcomes of the SP will be: i) An inventory of metadata schemas applied across infrastructures and domains; ii) The development of a framework for a metadata model characterising the research approach and workflow across research infrastructures; iii) The application of the framework to selected COVID-19 use cases; iv) The development of an ontology of COVID-19 related topics from parliamentary data and social media.
- 14 June 2023
- Published by Pensoft Publishers in ARPHA Preprints
- Vol. 4, e107873
Open AccessImproving COVID-19 metadata findability and interoperability in the European Open Science Cloud
This publication details the workplan of the Science Project (SP) “COVID-19 metadata findability and interoperability in EOSC” (short: META-COVID) that is part of the Horizon Europe funded project EOSC Future. The COVID-19 pandemic has generated a huge variety of research activities, studies, and policies across both the life sciences (LS) and the social sciences and humanities (SSH). Useful insights from combining the data and conclusions from these different forms of research are, however, hampered by the lack of a common metadata framework with which to describe them. This is because different scientific disciplines have different ways of organising research activities. For example, the type of the research (e.g., hypothesis testing versus hypothesis generating) and the methodology chosen (e.g., experimental, survey, cohort, case study) are key elements in understanding the data generated and in supporting its secondary use. Another issue to be tackled is the integration of various sources of metadata related to parliamentary and social media metadata. In META-COVID, scientists from the LS and SSH domains gathered to discuss ways in which metadata could go beyond the description of the data itself to include the basic elements of the research process (“contextual metadata”) within the frame of the European Open Science Cloud (EOSC). The main outcomes of the SP will be: i) An inventory of metadata schemas applied across infrastructures and domains; ii) The development of a framework for a metadata model characterising the research approach and workflow across research infrastructures; iii) The application of the framework to selected COVID-19 use cases; iv) The development of an ontology of COVID-19 related topics from parliamentary data and social media.
- 3 March 2017
- Published by Springer Nature
- Vol. 1575, 399-415
Cell and Tissue Imaging with Molecularly Imprinted Polymers
Advanced tools for cell imaging are of particular interest as they can detect, localize and quantify molecular targets like abnormal glycosylation sites that are biomarkers of cancer and infection. Targeting these biomarkers is often challenging due to a lack of receptor materials. Molecularly imprinted polymers (MIPs) are promising artificial receptors; they can be tailored to bind targets specifically, be labeled easily, and are physically and chemically stable. Herein, we demonstrate the application of MIPs as artificial antibodies for selective labeling and imaging of cellular targets, on the example of hyaluronan and sialylation moieties on fixated human skin cells and tissues. Thus, fluorescently labeled MIP nanoparticles templated with glucuronic acid (MIPGlcA) and N-acetylneuraminic acid (MIPNANA) are respectively applied. Two different fluorescent probes are used: (1) MIPGlcA particles, ~400 nm in size are labeled with the dye rhodamine that target the extracellular hyaluronan on cells and tissue specimens and (2) MIP-coated InP/ZnS quantum dots (QDs) of two different colors, ~125 nm in size that target the extracellular and intracellular hyaluronan and sialylation sites. Green and red emitting QDs are functionalized with MIPGlcA and MIPNANA respectively, enabling multiplexed cell imaging. This is a general approach that can also be adapted to other target molecules on and in cells.
- 3 March 2017
- Published by Springer Nature
- Vol. 1575, 399-415
Cell and Tissue Imaging with Molecularly Imprinted Polymers
Advanced tools for cell imaging are of particular interest as they can detect, localize and quantify molecular targets like abnormal glycosylation sites that are biomarkers of cancer and infection. Targeting these biomarkers is often challenging due to a lack of receptor materials. Molecularly imprinted polymers (MIPs) are promising artificial receptors; they can be tailored to bind targets specifically, be labeled easily, and are physically and chemically stable. Herein, we demonstrate the application of MIPs as artificial antibodies for selective labeling and imaging of cellular targets, on the example of hyaluronan and sialylation moieties on fixated human skin cells and tissues. Thus, fluorescently labeled MIP nanoparticles templated with glucuronic acid (MIPGlcA) and N-acetylneuraminic acid (MIPNANA) are respectively applied. Two different fluorescent probes are used: (1) MIPGlcA particles, ~400 nm in size are labeled with the dye rhodamine that target the extracellular hyaluronan on cells and tissue specimens and (2) MIP-coated InP/ZnS quantum dots (QDs) of two different colors, ~125 nm in size that target the extracellular and intracellular hyaluronan and sialylation sites. Green and red emitting QDs are functionalized with MIPGlcA and MIPNANA respectively, enabling multiplexed cell imaging. This is a general approach that can also be adapted to other target molecules on and in cells.